Barclays PLC acquired a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 20,992 shares of the company's stock, valued at approximately $385,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. BNP Paribas Financial Markets bought a new stake in Ardent Health Partners during the third quarter valued at approximately $42,000. Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners during the 3rd quarter worth $50,000. MetLife Investment Management LLC purchased a new position in Ardent Health Partners in the third quarter worth $135,000. Quadrature Capital Ltd bought a new position in Ardent Health Partners in the third quarter valued at $229,000. Finally, Centiva Capital LP purchased a new stake in Ardent Health Partners during the third quarter valued at about $469,000.
Analysts Set New Price Targets
A number of research firms have recently issued reports on ARDT. Truist Financial cut their price objective on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a report on Monday, January 6th. KeyCorp began coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an "overweight" rating and a $24.00 price target on the stock. Leerink Partners boosted their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a report on Tuesday, November 12th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, Royal Bank of Canada reissued an "outperform" rating and issued a $23.00 price target on shares of Ardent Health Partners in a research note on Thursday, November 14th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $22.00.
Read Our Latest Stock Report on ARDT
Ardent Health Partners Stock Performance
Shares of Ardent Health Partners stock traded up $0.30 during trading on Friday, reaching $14.10. 259,514 shares of the stock were exchanged, compared to its average volume of 214,527. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. Ardent Health Partners, LLC has a 1 year low of $13.69 and a 1 year high of $20.72. The stock's fifty day moving average is $16.28.
About Ardent Health Partners
(
Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Further Reading
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
